The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding Proteins
Mitchell, P. J., & Tjian, R. (1989) · Science · doi:10.1126/science.2667136 · Cited by 3,114
Type 2 diabetes: principles of pathogenesis and therapy
Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)61032-x · Cited by 2,662
Roles of PPARs in health and disease
Kersten, S., Desvergne, B., & Wahli, W. (2000) · Nature · doi:10.1038/35013000 · Cited by 1,956 · cited 1×
“Thiazolidinediones such as rosiglitazone and pioglitazone effectively reduce insulin resistance by targeting a nuclear receptor, peroxisome proliferator–activated receptor–γ (PPAR-γ); but the mechanism remains unclear [5,6].”
BackgroundPPARs and the complex journey to obesity
Evans, R. M., Barish, G. D., & Wang, Y.-X. (2004) · Nature Medicine · doi:10.1038/nm1025 · Cited by 1,602
Self-citationKong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., et al. (2004) · Nature Medicine · doi:10.1038/nm1135 · Cited by 1,391
Self-citationDresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311
Lee, Y. S., Kim, W. S., Kim, K. H., Yoon, M. J., Cho, H. J., Shen, Y., Ye, J.-M., Lee, C. H., Oh, W. K., Kim, C. T., et al. (2006) · Diabetes · doi:10.2337/db06-0006 · Cited by 1,054
Flier, J. S., Underhill, L. H., & Eckel, R. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904203201607 · Cited by 971
A new rat model of type 2 diabetes: The fat-fed, streptozotocin-treated rat
Reed, M. J., Meszaros, K., Entes, L. J., Claypool, M. D., Pinkett, J. G., Gadbois, T. M., & Reaven, G. M. (2000) · Metabolism · doi:10.1053/meta.2000.17721 · Cited by 848
Nesto, R. W., Bell, D., Bonow, R. O., Fonseca, V., Grundy, S. M., Horton, E. S., Le Winter, M., Porte, D., Semenkovich, C. F., Smith, S., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103683.99399.7e · Cited by 829
Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance
Kim, J. K., Fillmore, J. J., Chen, Y., Yu, C., Moore, I. K., Pypaert, M., Lutz, E. P., Kako, Y., Velez-Carrasco, W., Goldberg, I. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121164498 · Cited by 753
Guan, Y., Hao, C., Cha, D. R., Rao, R., Lu, W., Kohan, D. E., Magnuson, M. A., Redha, R., Zhang, Y., & Breyer, M. D. (2005) · Nature Medicine · doi:10.1038/nm1278 · Cited by 608
Hanson, R. L., Pratley, R. E., Bogardus, C., Narayan, K. M. V., Roumain, J. M. L., Imperatore, G., Fagot-Campagna, A., Pettitt, D. J., Bennett, P. H., & Knowler, W. C. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010187 · Cited by 463
Reduction of Polypharmacy in the Elderly: A Systematic Review of the Role of the Pharmacist
Rollason, V., & Vogt, N. (2003) · Drugs & Aging · doi:10.2165/00002512-200320110-00003 · Cited by 361
Structure of the human insulin receptor gene and characterization of its promoter.
Seino, S., Seino, M., Nishi, S., & Bell, G. I. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.1.114 · Cited by 361
Insulin Regulation of Lipolysis in Nondiabetic and IDDM Subjects
Jensen, M. D., Caruso, M., Heiling, V., & Miles, J. M. (1989) · Diabetes · doi:10.2337/diab.38.12.1595 · Cited by 331
Phillips, L. S., Grunberger, G., Miller, E., Patwardhan, R., Rappaport, E. B., Salzman, A., & the Rosiglitazone Clinical Trials Study Group (2001) · Diabetes Care · doi:10.2337/diacare.24.2.308 · Cited by 302
Insulin Resistance or Insulin Deficiency: Which Is the Primary Cause of NIDDM?
Taylor, S. I., Accili, D., & Imai, Y. (1994) · Diabetes · doi:10.2337/diab.43.6.735 · Cited by 289 · cited 1×
“Abnormality in InsR is of major importance to the development of insulin resistance, which is the underlying cause and essential component for type 2 diabetes mellitus and metabolic syndrome [2,3].”
BackgroundDrug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy
Grundy, S. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2005 · Cited by 287
Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality.
Joshi, R. L., Lamothe, B., Cordonnier, N., Mesbah, K., Monthioux, E., Jami, J., & Bucchini, D. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00498.x · Cited by 281
Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice
Foti, D., Chiefari, E., Fedele, M., Iuliano, R., Brunetti, L., Paonessa, F., Manfioletti, G., Barbetti, F., Brunetti, A., Croce, C. M., et al. (2005) · Nature Medicine · doi:10.1038/nm1254 · Cited by 219
Insulin signaling is required for insulin’s direct and indirect action on hepatic glucose production
Fisher, S. J., & Kahn, C. R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16426 · Cited by 211
FOTI, D. P., Iuliano, R., CHIEFARI, E. D., & Brunetti, A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2720-2732.2003 · Cited by 155
Abidi, P., Zhou, Y., Jiang, J.-D., & Liu, J. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000181761.16341.2b · Cited by 152
Self-citationNishino, Y., Miura, T., Miki, T., Sakamoto, J., Nakamura, Y., Ikeda, Y., Kobayashi, H., & Shimamoto, K. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.10.022 · Cited by 144
Araki, E., Shimada, F., UZAWA, H., Mori, M., & Ebina, Y. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47714-9 · Cited by 110
Vasudevan, A. R., & Balasubramanyam, A. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2004.6.850 · Cited by 110
Whetzel, A. M., Bolick, D. T., Srinivasan, S. R., Macdonald, T. L., Morris, M. A., Ley, K. F., & Hedrick, C. C. (2006) · Circulation Research · doi:10.1161/01.res.0000244088.33375.52 · Cited by 110
Transcriptional regulation of human insulin receptor gene by the high‐mobility group protein HMGI(Y)
Brunetti, A., Manfioletti, G., CHIEFARI, E. D., Goldfine, I. D., & FOTI, D. P. (2001) · The FASEB Journal · doi:10.1096/fj.00-0190com · Cited by 105
Bard-Chapeau, E. A., Hevener, A. L., Long, S., Zhang, E. E., Olefsky, J. M., & Feng, G. (2005) · Nature Medicine · doi:10.1038/nm1227 · Cited by 92
Ni, Y. X. (1988) · PubMed · Cited by 70
Pascoe, W. S., & Storlien, L. H. (1990) · Diabetes · doi:10.2337/diab.39.2.226 · Cited by 62
Human low-density lipoprotein receptor gene and its regulation
Kong, W., Liu, J., & Jiang, J. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0717-6 · Cited by 61
Self-citation[Studies on the hypoglycemic effect of Coptis chinensis and berberine].
Qm, C., & Mz, X. (1986) · PubMed · Cited by 57
Characterization of the promoter region of the human insulin receptor gene
Araki, E., Shimada, F., Fukushima, H., Mori, M., Shichiri, M., & Ebina, Y. (1989) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(89)90085-5 · Cited by 46
Mosaic analysis of insulin receptor function
Kitamura, T., Kitamura, Y., Nakae, J., Giordano, A., Cinti, S., Kahn, C. R., Efstratiadis, A., & Accili, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci17810 · Cited by 42
Molecular Basis of Insulin Action
González‐Sánchez, J. L., & Serrano‐Ríos, M. (2007) · Drug News & Perspectives · doi:10.1358/dnp.2007.20.8.1157615 · Cited by 40
Novel insulin sensitizers: pharmacogenomic aspects
Otto, C., Lehrke, M., & Göke, B. (2002) · Pharmacogenomics · doi:10.1517/14622416.3.1.99 · Cited by 33
Nakamaru, K., Matsumoto, K., Taguchi, T., Suefuji, M., Murata, Y., Igata, M., Kawashima, J., Kondo, T., Motoshima, H., Tsuruzoe, K., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.004 · Cited by 30
Up-Regulation of Cell Surface Insulin Receptor by Protein Kinase C-α in Adrenal Chromaffin Cells
Yamamoto, R., Kobayashi, H., Yanagita, T., Yokoo, H., Kurose, T., Shiraishi, S., Minami, S.-I., Matsukura, S., & Wada, A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750672.x · Cited by 15
Cited by
Zhang, X., Zhao, Y., Zhang, M., Pang, X., Xu, J., Kang, C., Li, M., Zhang, C., Zhang, Z., Zhang, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042529 · Cited by 615
“[38] also suggested that berberine restored the impaired insulin sensitivity in rats with type 2 diabetes via a mechanism of protein kinase C-dependent elevation of insulin receptor gene expression.”
BackgroundSelf-citationBiological properties and clinical applications of berberine
Song, D., Hao, J., & Fan, D. (2020) · Frontiers of Medicine · doi:10.1007/s11684-019-0724-6 · Cited by 496
Self-citationBerberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics
Feng, X., Sureda, A., Jafari, S., Memariani, Z., Tewari, D., Annunziata, G., Barrea, L., Hassan, S. T. S., Šmejkal, K., Malaník, M., et al. (2019) · Theranostics · doi:10.7150/thno.30787 · Cited by 465
Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms
Xu, L., Li, Y., Dai, Y., & Peng, J. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.015 · Cited by 452
Zhang, H., Wei, J., Xue, R., Wu, J.-D., Zhao, W., Wang, Z.-Z., Wang, S.-K., Zhou, Z.-X., Song, D.-Q., Wang, Y.-M., et al. (2010) · Metabolism · doi:10.1016/j.metabol.2009.07.029 · Cited by 440
Self-citation
Metadata
- Authors
- Kong, W.-J., Zhang, H., Song, D.-Q., Xue, R., Zhao, W., Wei, J., Wang, Y.-M., Shan, N., Zhou, Z.-X., Yang, P., You, X.-F., Li, Z.-R., Si, S.-Y., Zhao, L.-X., Pan, H.-N., & Jiang, J.-D.
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 58
- Issue
- 1
- Pages
- 109-119
- ISSN
- 0026-0495 (ISSN-L)
- OpenAlex
- W2066990455
- Cited by
- 267
- References
- 40
- FWCI
- 6.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.